541 related articles for article (PubMed ID: 30482583)
1. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
[TBL] [Abstract][Full Text] [Related]
3. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
4. Detecting multiple sclerosis via breath analysis using an eNose, a pilot study.
Ettema AR; Lenders MWPM; Vliegen J; Slettenaar A; Tjepkema-Cloostermans MC; de Vos CC
J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33271513
[TBL] [Abstract][Full Text] [Related]
5. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
[TBL] [Abstract][Full Text] [Related]
7. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of soft tissue sarcoma using volatile organic compounds in exhaled breath: a pilot study.
Acem I; van Praag VM; Mostert CQ; van der Wal RJ; Neijenhuis RM; Verhoef C; Grünhagen DJ; van de Sande MA
Future Oncol; 2023 Mar; 19(10):697-704. PubMed ID: 37129048
[TBL] [Abstract][Full Text] [Related]
9. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
[TBL] [Abstract][Full Text] [Related]
11. Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis.
Kort S; Tiggeloven MM; Brusse-Keizer M; Gerritsen JW; Schouwink JH; Citgez E; de Jongh FHC; Samii S; van der Maten J; van den Bogart M; van der Palen J
Lung Cancer; 2018 Nov; 125():223-229. PubMed ID: 30429025
[TBL] [Abstract][Full Text] [Related]
12. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
13. Data analysis of electronic nose technology in lung cancer: generating prediction models by means of Aethena.
Kort S; Brusse-Keizer M; Gerritsen JW; van der Palen J
J Breath Res; 2017 Jun; 11(2):026006. PubMed ID: 28373602
[TBL] [Abstract][Full Text] [Related]
14. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
[TBL] [Abstract][Full Text] [Related]
15. Pilot Study: Detection of Gastric Cancer From Exhaled Air Analyzed With an Electronic Nose in Chinese Patients.
Schuermans VNE; Li Z; Jongen ACHM; Wu Z; Shi J; Ji J; Bouvy ND
Surg Innov; 2018 Oct; 25(5):429-434. PubMed ID: 29909757
[TBL] [Abstract][Full Text] [Related]
16. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
[TBL] [Abstract][Full Text] [Related]
17. Detection of differentiated thyroid carcinoma in exhaled breath with an electronic nose.
Scheepers MHMC; Al-Difaie ZJJ; Wintjens AGWE; Engelen SME; Havekes B; Lubbers T; Coolsen MME; van der Palen J; van Ginhoven TM; Vriens M; Bouvy ND
J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35688135
[TBL] [Abstract][Full Text] [Related]
18. Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.
Dragonieri S; Quaranta VN; Carratù P; Ranieri T; Buonamico E; Carpagnano GE
Molecules; 2021 May; 26(9):. PubMed ID: 34064506
[TBL] [Abstract][Full Text] [Related]
19. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
[TBL] [Abstract][Full Text] [Related]
20. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
